Clinical Trial: 5-Fluorouracil and Calcipotriene for Field Treatment of Actinic Keratoses

U.S., Sept. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07794059) titled '5-Fluorouracil and Calcipotriene for Field Treatment of Actinic Keratoses' on Aug. 26.

Brief Summary: Combination field therapy with 5-fluorouracil and calcipotriene (5FU/C) has become standard of care among dermatologists for the field treatment of diffuse actinic keratoses (AKs). Data suggest that the addition of calcipotriene elicits a sustained T cell memory allowing for both short and long-term AK clearance. Our objective is to evaluate the efficacy, as well as, document the timing, severity and duration of local cutaneous reactions to topical treatment with 5FU/C for the treatment of AKs.

Study Start Date: Sept., 2026

Study ...